COHERUS BIOSCIENCES INC. - COMMON STOCK

Coherus BioSciences Announces New Employment Inducement Grants

16 Dec 2021 16:30:00 By Nasdaq GlobeNewswire

Coherus and Junshi Biosciences Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

13 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Coherus and Junshi Biosciences Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer

15 Nov 2021 08:30:00 By Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

10 Nov 2021 16:15:01 By Nasdaq GlobeNewswire

Coherus BioSciences Reports Third Quarter 2021 Results

08 Nov 2021 16:01:00 By Nasdaq GlobeNewswire

Coherus BioSciences Announces CMS Has Extended Enhanced Medicare Reimbursement for UDENYCA® in the 340B Hospital Setting Through Year-End 2022

05 Nov 2021 08:30:00 By Nasdaq GlobeNewswire

Coherus and Junshi Biosciences Announce FDA Acceptance of BLA Filing for Toripalimab for Treatment of Nasopharyngeal Carcinoma

01 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Coherus BioSciences to Report Third Quarter 2021 Financial Results on November 8th

29 Oct 2021 16:11:55 By Nasdaq GlobeNewswire

Coherus BioSciences Mourns the Passing of Board Member Alan C. Mendelson

11 Oct 2021 08:30:00 By Nasdaq GlobeNewswire

Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial

05 Oct 2021 08:00:01 By Nasdaq GlobeNewswire